Management Of Tuberculosis In Patients On Tnf Alpha Inhibitors

Management of Tuberculosis in Patients on TNF alpha Inhibitors

Global Tuberculosis Institute

Beyond TNF Inhibitors: TB in the Age of Biologics

Four Nearly Absolute Contraindications to Using TNF Inhibitors

How TNF causes pathogenic cell death in tuberculosis by Dr. Lalita Ramakrishnan

GLOBAL IMMUNOTALKS

TNF Inhibitors and Autoimmune Disease

Specialty Pharmacy Times

Tuberculosis and Biologics: Relating Mechanisms Action Immunopathogenesis Granulomatous Infections

ClevelandClinicCME

Tumor Necrosis Factor (TNF) Blockers and Tuberculosis: A Case Presentation and Review of Literature

Role of TNF-alpha Inhibitors in Crohn’s Disease

Do TNF blockers increase infection rates?

TNF Inhibitors: An Overview

AlbertaRheumatology

Spotlight on Testing: Test-Guided Management of Treatment Failure to TNF-alpha Antagonists

ARUP Laboratories

Advances in the Efficacy and Safety of TNF Inhibitors - Ep. 4

ClevelandClinicCME

Before starting a patient on TNF alpha inhibitors, it's important to check for active or latent TB.

Dr. Apurva Popat

Detection of Latent TB infection in Immunosuppressed Patient - IGRA Vulnerable Population

ClevelandClinicCME

QD 80 - Latent TB

Anti-TNF Treatment Tied to Reduced CV Risk

MDedge: news and insights for busy physicians

Ask The Experts Webinar: Clinical Conundrums in LTBI Treatment

Consequences of TNF Inhibition

The treatment of moderate to severe IBD with anti-TNF biologics and immunomodulators

TNF Inhibitors: Patient Selection